Drug Safety MENA Summit
Saudi FDA: Working with Industry to Improve the Reporting of Adverse Reactions
March 29 by Dr Nasser Al-QahtaniDr. Nasser Al-Qahtani, Head, Adverse Drug Reactions Evaluations Department, Saudi FDA, joins Pharma IQ to discuss the Saudi FDA’s pharmacovigilance system and what new guidelines he predicts will be a...